Hoylu AB: Bulletin from the Annual General Meeting in Hoylu

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
154
Hoylu AB: Bulletin from the Annual General Meeting in Hoylu AB (Publ)


Distribution of earnings Accommodation.
At the Annual General Meeting of Hoylu AB (Publ) today, May 16, 2018, the AGM adopted the income statements and balance sheets of the parent company and the Group for 2017 and resolved in accordance with the proposal by the Board and the CEO that no dividend should be paid and that the unrestricted equity in the parent company shall be carried forward. The AGM discharged the members of the Board and the CEO from liability.

Board of Directors and Auditor
The AGM resolved to re-elect Mats Andersson, Stein Revelsby and Jon Ullmark. Mats Andersson was re-elected as the Chairman of the Board.

The AGM resolved to elect Ian Sandmæl as a new board member to replace Anna Anderberg. Ian Sandmæl, born 1974, Co-founder and CEO of Work, a consulting firm in product design based in Oslo. Ian has a bachelor's degree in product design from Art Center College, Pasadena, California. Ian has previously employed at IDEO in San Francisco where he worked with major international clients such as Microsoft and Procter & Gamle.

The AGM resolved that the total remuneration for the Board of Directors shall be SEK 250,000 to the Chairman of the Board and SEK 150 000 to the other board members except Stein Revelsby (Chief Executive officer), for a total fee of SEK 550 000.

The AGM resolved to re-elect the registered audit firm Deloitte, for the period until the end of the next AGM, as the Company's Auditor. The AGM resolved that the audit fees shall be paid in accordance with approved invoices.

Amendment of Articles of Association
The AGM resolved to adopt new Articles of Association whereby the share capital was changed from the current the current minimum of SEK 500,000 and maximum of SEK 2,000,000 to at least SEK 760,000 and not more than SEK 3,040,000 and the limits on the number of shares were changed from the current minimum 4,225,000 and no more than 16,900,000 to at least 6,422,000 and a maximum of 25,688,000.

Issuance Authorization
The AGM resolved to authorize the Board, with or without deviation from the shareholders' preferential rights; at one or more occasions and at the until the next AGM, to increase the Company's share capital through new issue of shares, warrants, or convertible notes to the extent permitted by the Articles of Association.

Warrant Program
The AGM resolved to introduce a warrant program. The right to participate in the warrant program shall be the limited to senior executives of the company or its subsidiaries. Each warrant entitles the holder to subscribe for a new share in the company against payment according to a subscription price amounting to the higher of; (i) an amount equal to 140 per cent of the company's shares listed weighted average price for a period from May 11, 2018 to May 15, 2018; and (ii) SEK 10.00 per share, however the subscription price shall be at least equal to the quotient value. The warrants shall have a maturity of 3.5 years with the possibility to exercise the warrant after three years.

To enable the delivery of warrants under the warrant program the AGM also resolved the undertaking of a directed share issue of up to 376,546 warrants to one of the Company's wholly owned subsidiaries and the transfer of warrants from the subsidiary to participants in the warrant program.

Upon full exercise of the warrants, up to 376,546 shares may be issued, which corresponds to a dilution of approximately 2.47 percent of the Company's share capital and votes.

Employee stock Option Program
The AGM resolved to introduce an employee stock option program by issuing a maximum of 3,095,404 options. The right to participate in the employee stock option program shall be limited to the Company's CEO, senior executives, and certain employees and long-term consultants of the Company or its subsidiaries. Each stock options gives the right to subscribe for a new share in the Company against payment according to a subscription price amounting to the higher of; (i) an amount equal to 140 per cent of the Company's shares listed weighted average price for a period from May 11, 2018 to May 15, 2018; and (ii) SEK 10.00 per share, however, the subscription price shall be at least equal to the quota value of the share.

In order to allow the delivery of shares under the employee stock option program, the AGM also resolved the undertaking of a directed issue of 3,095,404 options to one of the Company's wholly owned subsidiaries and the transfer of the options from the subsidiary to participants in the employee stock option program.

Upon full exercise of the options, up to 3,095,404 shares may be issued, which corresponds to a dilution of approximately 17.23 percent of the Company's share capital and votes.

For more information, please contact:
Stein Revelsby, CEO Hoylu + 1 213 440 2499 Email: sr@hoylu.com
Karl Wiersholm, CFO Hoylu + 1 425 829 2316 Email: kw@hoylu.com

About Hoylu
Hoylu delivers innovative solutions to allow global collaborative teams plan, create and share information that will enrichen the user experience in the virtual office. The Hoylu Suite delivers a comprehensive set of personalized digital workspaces to enable teams across locations, on any device, to work smarter and with more fun across major industries including Engineering, Education, Pharmaceutical, Construction, Manufacturing, Graphic Design and many more.

For more information visit:
Www.hoylu.com or Www.introduce.se/foretag/hoylu

Ticker: Hoylu
Marketplace: Nasdaq First North Stockholm
Certified Adviser: Mangold Brokerage AB + 46 (0) 8 50 301 550

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading